Tuesday November 19, 2019
Home India Delhi HC says...

Delhi HC says license guidelines are “unfair”

0
//

By NewsGram Staff Writer

New Delhi: Guidelines issued by the transport department for granting license to motor driving schools might be changed again, as the Delhi High Court deemed “unfair” the provisions regarding infrastructure and financial solvency of the schools.

Delhi-High-CourtIn a hearing on Monday, the Delhi High Court stated that the “definition” of “close relatives” in the guidelines for granting license to motor driving training schools, by the Delhi government is very “vague.”

The All Delhi Motor Driving Training Schools Association, challenged these guidelines before the High Court stating that they violate the fundamental right to trade or occupation, as well as the right to equality of the companies running the schools.

According to the guidelines, “close relatives” of transport department officials cannot be a member or director of the school applying for license.

The association, in its appeal to the court, argued that the provision barring “close relatives of current transport department officials” violated the right to freedom of occupation under Article 19 as well as right to equality.

Next Story

Delhi High Court Directs Private Clinic to Continue with the Stem Cell Treatment

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained

0
Order
Delhi High Court. Source- Wikimedia

In an interim relief, the Delhi High Court has directed a private clinic to continue with the stem cell treatment being provided to the patients till its further orders.

The court’s interim direction came while hearing various petitions challenging the Centre’s decision to put stem cell therapy in the category of new drugs.

The petitioners were being provided stem cell treatment in Nutech Mediworld Clinic in Green Park here.

A Division Bench of justices Anu Malhotra and Talwant Singh said that all details of treatment being provided to the petitioners by the clinic be placed on record with an affidavit.

Representational image.

The court has sought the response of Centre and Indian Council of Medical Research to file reply on the petition and listed the matter for September 4 for further hearing.

The court has directed authorities concerned to examine whether the products being administered to the petitioners, prima facie, fall within the scope of the expression ‘new drugs’ as defined under Rule 2(1) (w) of New Drugs and Clinical Trial Rules, 2019 and communicate the view to the petitioners and the said clinic.

Also Read- LG CNS, Microsoft to Develop Cloud-based Enterprise Solutions

On account of the Centre’s fresh notification on ‘New Drugs and Clinical Rule 2019’, some medications used for the treatment would fall under the definition of ‘new drug’ and require approval from the authority concerned.

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained. (IANS)